0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight chronic obstructive pulmonary disease copd api insights 2014.Your search for "" gave back 962408 results.
The global Muscarinic Acetylcholine Receptor market size was valued at US$ 157.5 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Muscarinic Acetylcholine Receptor (m-g protein coupled Receptor) is an autoantibody in the serum of patients with myasthenia gravis. The global...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) Development by Therapy Areas and Indications, Stages,...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Leukotriene A 4 Hydrolase - Drugs In Development, 2021 Summary Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Leukotriene A 4 Hydrolase - Pipeline Review, H1 2020 Summary According to the recently published report 'Leukotriene A 4 Hydrolase - Pipeline...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Leukotriene A 4 Hydrolase - Pipeline Review, H2 2019 Summary Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Aerosol is a system in which fine solid or liquid droplets are suspended in another gas, which are present in the colloidal form. Aerosol is used to...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 2018 Summary Leukotriene A 4...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
The global Chronic Obstructive Pulmonary Disease Treatment market was valued at US$ 17330 million in 2023 and is anticipated to reach US$ 21370...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H1 2020 Summary Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
COPD inhaler is a therapeutic device for patients with chronic obstructive pulmonary disease (COPD), designed to deliver inhaled medication directly...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
HFCWO therapy involves the use of a respiratory vest that is connected to a generator with a single-hose. The technology delivers rapidly repeating...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Highlights The global Chronic Obstructive Pulmonary Disease Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
